Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2014
At a glance
- Drugs Verubulin (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma
- Focus Therapeutic Use
- 13 Oct 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 13 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2011 Results from bevacizumab-naive patients presented at the 47th Annual Meeting of the American Society of Oncology (ASCO-2011).